Market revenue in 2023 | USD 140.3 million |
Market revenue in 2030 | USD 222.7 million |
Growth rate | 6.8% (CAGR from 2023 to 2030) |
Largest segment | Oral |
Fastest growing segment | Oral |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oral, Enteral |
Key market players worldwide | Abbott Laboratories, Danone SA, Fresenius SE & Co KGaA, Nestle SA, Meiji Holdings Co Ltd, Reckitt Benckiser Group PLC, Victus, Primus Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to enteral feeding formulas market will help companies and investors design strategic landscapes.
Oral was the largest segment with a revenue share of 96.44% in 2023. Horizon Databook has segmented the Japan enteral feeding formulas market based on oral, enteral covering the revenue growth of each sub-segment from 2018 to 2030.
Growing geriatric population in Japan is likely to drive the demand for enteral feeding formulas market in the country over the forecast period. According to World Bank, in 2021, over 30% of the Japanese population was aged 65 & above.
The geriatric population is at a higher risk of chronic diseases, which is expected to propel the growth of enteral feeding formulas market in this country. In addition, with increasing healthcare spending, enteral feeding formulas market is expected to witness substantial growth in Japan over the forecast period.
For instance, healthcare expenditure in Japan increased from 9.06% in 2010 to 10.74% in 2019. Moreover, increasing prevalence of cancer and lifestyle diseases is likely to boost the enteral feeding formulas market in Japan. For instance, in 2021, 1,024,982 new cancer cases were reported in Japan and 1,096,955 new cases are estimated to be reported in Japan.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan enteral feeding formulas market , including forecasts for subscribers. This country databook contains high-level insights into Japan enteral feeding formulas market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account